ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ)
$3.99 0.07 (1.7857%)
Analysed ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) News Sources
TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates
06-05-2026
yahoo.com
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
07-05-2026
yahoo.com
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027
12-05-2026
yahoo.com
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
12-05-2026
yahoo.com
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Lags Revenue Estimates
12-05-2026
yahoo.com
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
19-05-2026
yahoo.com
Favourable Signals For Orchestra BioMed Holdings: Numerous Insiders Acquired Stock
21-05-2026
yahoo.com
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-06-2026
yahoo.com
Sidoti Events, LLC's June Small-Cap Virtual Conference
16-06-2026
yahoo.com
Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes
29-06-2026
yahoo.com
What is the current price of ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ)?
The current price of ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) is $3.99.
ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) since the previous trading day is $0.07.
ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) since the previous trading day is 1.7857%.
What is the most recent average sentiment score for ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ)?
The most recent average sentiment score for ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ)?
The most recent sentiment for ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ) is .
SEC-8K** Filing Available For ORCHESTRA BIOMED HOLDINGS IN (OBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.